For people put off IUDs by fears of painful placement, a simple step that needs no special equipment could make a real difference.
Written by: Lisa Vossen & Melanie CustodioAnyone who has researched IUDs has probably come across the same warning, repeated in different words across forums and social media: placement can really hurt. For some people it's a brief cramp; for others, it's bad enough to make them reconsider the whole method. That fear is well documented in the medical literature too and it's one of the reasons some people avoid IUDs altogether, even though the devices themselves are extremely effective and low maintenance.
The frustrating part has been the lack of a reliable fix. Numbing gel and cervical injections have shown some benefit in trials, but can be uncomfortable themselves. Injectable options like nerve blocks also aren’t something every outpatient clinic is set up to do. A team at Danderyd Hospital and the Karolinska Institutet in Stockholm set out to test a more modest intervention: instilling a local anesthetic directly into the uterine cavity through a thin catheter, two minutes before the IUD is placed. [1]
What they did
The trial ran at 11 clinics across Sweden between 2021 and 2024 and enrolled 370 people aged 18 to 31 who had never been pregnant to term and were getting an IUD with a smaller placement tube (either a low-dose hormonal IUD or a copper IUD). Half were randomly assigned to receive 10 mL of mepivacaine instilled into the uterus; the other half received the same volume of plain saline as a placebo. Neither participants nor the clinicians placing the IUD knew which fluid was being used, since the two liquids look, feel, and smell the same.
Pain was measured with a standard 100-millimeter visual scale at several points: before anything happened, right after the rinse, during the IUD placement itself, and ten minutes later. Participants also answered simple yes/no and experience questions — was the pain tolerable, was it easier than expected, would they choose an IUD again. [1]
What they found
The headline number: average pain during placement was 43.8 out of 100 in the mepivacaine group versus 58.6 in the placebo group — a difference of about 15 points on the 0–100 scale (14.8 mm, 95% CI 10.0–19.6; P < .001). That gap held up even after accounting for which clinician performed the procedure (adjusted difference 14.2 mm, 95% CI 9.7–18.6; P < .001).
The secondary results told a consistent story. People in the mepivacaine group were more likely to rate the pain as tolerable (98.3% versus 91.4%), more likely to say they'd choose an IUD again (93.2% versus 82.0%), and less likely to faint or feel lightheaded during the procedure (7.9% versus 18.2%). They were also less likely to say the experience was worse than they'd expected going in.
Importantly, the rinse itself wasn't painful — almost everyone (98.9%) rated the rinse itself as tolerable, mepivacaine or not. And there were no serious adverse events in either group over three months of follow-up. [1]
Why it's a credible result
A few things make this trial worth paying attention to, beyond the obvious numbers. It was reasonably large and multicenter, run across 11 clinics with 28 different clinicians, which makes the result more likely to generalize rather than reflect one particularly skilled provider. It was properly blinded on both sides — participants and clinicians alike — which matters a lot for a pain outcome, since pain perception is notoriously sensitive to expectation. [1] And this isn't a one-off finding: the same research group ran an earlier trial of the identical approach with a different (larger) IUD type and saw a similar-sized benefit, which supports the idea that the effect is real rather than a fluke of one device or one patient population. [2]
The authors are appropriately cautious about the limits. The study wasn't designed to compare this method against other pain-relief options like numbing gel or a cervical block, so it can't say which approach is best — only that this one beats doing nothing. It also couldn't fully rule out that the act of rinsing the uterus with any fluid has some pain-blunting effect of its own, independent of the anesthetic, but given the results, it seems unlikely. [1]
What it could mean
If this approach holds up and spreads into routine practice, it could lower one of the real barriers to IUD use: the fear of an unpredictably painful procedure. It doesn't require special training, sedation, or equipment beyond a catheter most clinics could stock — which matters, because the more complicated a pain-relief method is, the less likely it is to actually get used in a busy outpatient clinic.
It's one trial, in one country's clinics, in a specific age range of people who hadn't given birth before. But it's a well-designed one, and it adds real weight to a question that's mattered to a lot of people trying to make an informed choice about contraception
FAQs
-
It is a simple numbing method where a doctor uses a thin tube to gently rinse the inside of the uterus with liquid numbing medicine (mepivacaine) two minutes before placing an IUD. Unlike injections or nerve blocks, it doesn't require needles, sedation, or special equipment.
-
Yes. In a Swedish clinical trial of 370 participants, those who received the mepivacaine rinse reported an average pain score of 43.8 out of 100 during placement, compared to 58.6 in the group that received a plain saline placebo—a statistically significant drop of about 15 points.
-
Beyond lower average pain scores, participants who received the numbing rinse were more likely to rate the pain as tolerable (98.3% versus 91.4%), more likely to say they would choose an IUD again (93.2% versus 82.0%), and less than half as likely to faint or feel lightheaded during the procedure (7.9% versus 18.2%). They were also less likely to say the experience was worse than expected.
-
No. Nearly every participant in the study (98.9%) rated the fluid rinse itself as tolerable, regardless of whether they received the anesthetic or the saline placebo.
-
Yes. Researchers followed participants for three months after their IUD placement and reported zero serious adverse events in either the anesthetic or placebo group.
-
The trial enrolled 370 people aged 18 to 31 across 11 clinics in Sweden who had never carried a pregnancy to term and were receiving a smaller-tube IUD (either a copper IUD or a low-dose hormonal IUD). Notably, the same research team previously found a similar pain-reducing benefit using this exact method with larger IUDs.
-
Not necessarily. Because this trial compared the anesthetic rinse against a plain saline placebo rather than against other pain-relief methods, it shows that the rinse works better than no medication—not whether it outperforms topical gels, sprays, or cervical blocks.
-
While this technique isn't yet standard practice everywhere, it uses basic supplies that most outpatient clinics already carry. If you are planning to get an IUD, these findings give you concrete evidence to bring up with your provider when asking about local pain-relief options—whether that is an intrauterine rinse, numbing gel, or a cervical block.
Sources
Elgemark K, Envall N, Kopp Kallner H. Intrauterine Mepivacaine Instillation vs Placebo for Pain During IUD Placement: A Randomized Clinical Trial. JAMA. 2026;336(16):1436–1443. doi:10.1001/jama.2026.14217
Envall N, Elgemark K, Kopp Kallner H. Mepivacaine instillation for pain reduction during intrauterine device placement in nulliparous women: a double-blinded randomized trial. Am J Obstet Gynecol. 2024;231(5):524.e1–524.e7. doi:10.1016/j.ajog.2024.05.0